Cipla signs definitive agreement to acquire stake in subsidiary

07 Aug 2019 Evaluate

Cipla has signed definitive agreement to acquire the minority stake of Eight Roads Investment Mauritius II in its subsidiary -- Cipla Health. The transaction is expected to be completed within a month.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1413.70 56.75 (4.18%)
15-May-2024 10:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.30
Dr. Reddys Lab 5936.40
Cipla 1413.70
Zydus Lifesciences 995.30
Lupin 1638.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.